Fibromyalgia or MS: How to Recognize the Key Differences in Your Symptoms

If you’re reading this, you might be feeling confused or worried about your current symptoms. Maybe you’ve been experiencing widespread pain, overwhelming fatigue, or neurological symptoms like numbness or vision changes, and you’re trying to understand whether what you’re experiencing could be fibromyalgia or multiple sclerosis (or something else entirely). That uncertainty can feel overwhelming, and you’re not alone in seeking answers.

You’re not imagining that these conditions can feel similar; research actually confirms why distinguishing between them can be challenging. Both fibromyalgia and MS can cause overlapping symptoms like pain and fatigue, which makes the diagnostic process complex, even for experienced healthcare providers. 

The encouraging news is that research has helped us understand much more about how these conditions differ, and there are healthcare providers who specialize in helping people navigate these diagnostic questions. You deserve clear answers and compassionate care as you work toward understanding what’s happening in your body.

Understanding the Key Differences Between Fibromyalgia and MS

Fibromyalgia and multiple sclerosis affect your body in fundamentally different ways, even when some symptoms overlap. Understanding these differences can help you better describe your experience to healthcare providers and know what to expect during evaluation.

How These Conditions Work Differently in Your Body

Fibromyalgia involves your nervous system becoming hypersensitive to various stimuli. Fibromyalgia involves your nervous system becoming hypersensitive to pain signals¹. People with fibromyalgia process pain differently, with the brain and spinal cord amplifying sensations that wouldn’t normally be painful.

Multiple Sclerosis (MS) works through a completely different mechanism. MS is an autoimmune disorder where the immune system mistakenly attacks myelin, the protective sheath around nerve fibers in the central nervous system.³  This leads to inflammation, damage and disruption of nerve signals.

How Pain Feels Different

The way pain shows up in these conditions can help distinguish between them. With fibromyalgia, you may experience widespread pain that affects multiple areas of your body, often described as aching, burning, or like a deep muscle soreness that never goes away. This pain typically occurs on both sides of your body and both above and below your waist⁵.

With MS, pain often has a different quality and pattern. You might experience sharp, shooting pains along nerve pathways, or burning sensations that follow specific nerve distributions. MS pain is more likely to affect one side of your body or specific areas rather than being widespread.

How Fatigue Differs

Both conditions can cause profound fatigue, but the experience often feels different. Fibromyalgia fatigue is typically constant and unrefreshing. It is often described as feeling exhausted even after a full night’s sleep. Research published in BMC Musculoskeletal Disorders in 2007 found that about 9 in 10 people with fibromyalgia experience this type of persistent fatigue². You may experience this overwhelming fatigue that feels like your body’s energy is completely depleted.

MS fatigue can feel different. It is an often sudden, overwhelming exhaustion that can come on without warning. Some people with MS experience what’s called “lassitude,” which feels like your energy has been completely drained, often triggered by heat or physical exertion¹⁹.

Neurological Symptoms

This is often where the conditions differ most clearly. MS commonly causes specific neurological symptoms like³:

• Vision problems, often affecting one eye
• Numbness or tingling that follows nerve pathways
• Muscle weakness in specific muscle groups
• Balance problems or dizziness
• Problems with coordination

While fibromyalgia can cause cognitive symptoms like brain fog, it typically doesn’t cause the specific neurological symptoms seen in MS.

Symptom Patterns Over Time

The way symptoms behave over time can also provide clues. MS symptoms often come in distinct episodes. You might have weeks or months of specific symptoms, then they improve or disappear completely before new symptoms appear. This pattern is called “relapsing-remitting”⁴.

Fibromyalgia symptoms tend to be more consistent day-to-day, though they can vary in intensity¹⁶. You might have better days and worse days, but the underlying symptoms typically don’t disappear completely for extended periods. Many people notice their symptoms can be affected by factors like weather changes, stress, or sleep quality.

Why Symptom Overlap Can Feel Confusing

You’re not imagining the similarities. Research validates why these conditions can feel confusing to distinguish. Both can cause pain and fatigue, but studies show the patterns tend to differ in the ways described above. This overlap is why careful evaluation by healthcare providers familiar with both conditions is so important.

When Conditions Overlap

It’s important to know that having one condition doesn’t rule out the other. Research published in Medical Science Monitor in 2014 found that about 1 in 6 people with MS may also experience fibromyalgia-like symptoms⁶. This means some people may have both conditions, which is why careful evaluation by specialists familiar with both conditions is often necessary.

Understanding these differences can help you provide more detailed information to your healthcare providers, and if you’re trying to understand your symptom patterns, our fibromyalgia symptoms checklist can help you prepare for productive conversations with healthcare providers. Remember that only qualified medical professionals can make accurate diagnoses based on comprehensive evaluation of your individual symptoms and medical history.

Who Should You Turn to for Help with MS or Fibromyalgia?

Specialist evaluation plays an important role in managing both conditions, and understanding different approaches can help you know what to expect and advocate for appropriate care.

Neurologist Consultation for MS Evaluation

If you’re experiencing symptoms like vision changes, numbness, or muscle weakness, you may be referred to a neurologist. Using the 2017 McDonald criteria, which rely on MRI imaging and, in some cases, cerebrospinal fluid testing, neurologists can often diagnose MS more quickly¹³. This updated approach allows treatments to begin sooner when MS is confirmed.

Rheumatologist Consultation for Fibromyalgia Evaluation

If you’re dealing with widespread pain, fatigue, and sleep difficulties, seeing a rheumatologist or fibromyalgia specialist may be helpful. These providers are skilled in applying the 2016 ACR criteria for diagnosing fibromyalgia,¹⁴ and their experience can improve accuracy, especially in complex cases.

Finding fibromyalgia specialists who understand these complex conditions can make a significant difference in your care experience and help ensure you receive thorough, compassionate evaluation.

Coordinated Care for Complex Cases

Given that both conditions can occur together, some people may benefit from evaluation by multiple specialists. Studies support a collaborative approach when symptoms are complex or when one condition doesn’t fully explain your experience¹⁴. This doesn’t indicate any problems with your specific case. It represents thorough, comprehensive care.

When to Seek Professional Evaluation

You deserve professional evaluation if you’re experiencing persistent symptoms that interfere with your daily life. Consider consulting with specialists if you have widespread pain lasting more than three months, neurological symptoms like numbness or vision changes, or if your current healthcare provider suggests specialist input.

Both fibromyalgia and MS benefit from early appropriate care, and seeking evaluation doesn’t commit you to any particular diagnosis or treatment approach.

How Swing Care Can Help

At Swing Care, we understand that navigating diagnostic uncertainty can feel overwhelming. Our fibromyalgia specialists use evidence-based approaches to help you understand your symptoms and develop comprehensive care plans that address your individual experience.

We work collaboratively with your existing healthcare team and can help coordinate care when multiple specialists are involved. Whether you’re still seeking a diagnosis or need better management of confirmed fibromyalgia, we’re here to provide the specialized, compassionate care you deserve.

You can learn more about evidence-based fibromyalgia treatment approaches and explore fibromyalgia medications and treatment options that may be helpful regardless of your specific diagnostic journey.

Key Takeaways

Current research shows that fibromyalgia and MS are distinct conditions with different underlying causes, though they can share some symptoms like pain and fatigue. While diagnostic complexity is real and supported by medical studies, specialist evaluation can provide the clarity you’re seeking.

Your individual experience may differ from research averages, and both conditions benefit from comprehensive, evidence-based care approaches. Remember that research continues to improve our understanding of both conditions, and transparent acknowledgment of diagnostic challenges helps advance better care for everyone.

This information represents current medical evidence as of January 2025 and is intended for educational purposes only. Fibromyalgia and multiple sclerosis diagnosis and treatment decisions should be made collaboratively with qualified healthcare providers who can assess individual circumstances. Diagnostic accuracy and timelines vary significantly between individuals based on presentation, healthcare access, and specialist availability. This content does not constitute medical advice, diagnoses, or treatment recommendations.

Medically reviewed by Dr. Andrea Chadwick, MD, MSc, FASA

Sources

1. Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547-1555. https://pubmed.ncbi.nlm.nih.gov/24737367/
2. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007;8:27. https://pubmed.ncbi.nlm.nih.gov/17349056/
3. National Institute of Neurological Disorders and Stroke. (2025, January 31). Multiple sclerosis. National Institutes of Health. https://www.ninds.nih.gov/health-information/disorders/multiple-sclerosis
4. Tafti D, Ehsan M, Xixis KL. Multiple Sclerosis. [Updated 2024 Mar 20]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499849/
5. Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319-329. https://pubmed.ncbi.nlm.nih.gov/27916278/
6. Clemenzi, A., Pompa, A., Casillo, P., Pace, L., Troisi, E., Catani, S., & Grasso, M. G. (2014). Chronic pain in multiple sclerosis: is there also fibromyalgia? An observational study. Medical science monitor : international medical journal of experimental and clinical research, 20, 758–766. https://doi.org/10.12659/MSM.890009
7. Vincent A, Lahr BD, Wolfe F, et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res. 2013;65(5):786-792. https://pubmed.ncbi.nlm.nih.gov/23203795/
8. Brownlee WJ, Hardy TA, Fazekas F, Miller DH. Diagnosis of multiple sclerosis: progress and challenges. Lancet. 2017;389(10076):1336-1346. https://pubmed.ncbi.nlm.nih.gov/27889190/
9. Choy, E., Perrot, S., Leon, T., Kaplan, J., Petersel, D., Ginovker, A., & Kramer, E. (2010). A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC health services research, 10, 102. https://doi.org/10.1186/1472-6963-10-102
10. Gendelman, O., Amital, H., Bar-On, Y., Ben-Ami Shor, D., Amital, D., Tiosano, S., Shalev, V., Chodick, G., & Weitzman, D. (2018). Time to diagnosis of fibromyalgia and factors associated with delayed diagnosis in primary care. Best practice & research. Clinical rheumatology, 32(4), 489–499. https://doi.org/10.1016/j.berh.2019.01.019
11. White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol. 1999;26(7):1570-1576. https://pubmed.ncbi.nlm.nih.gov/10405947/
12. Schwenkenbecher, P., Wurster, U., Konen, F. F., Gingele, S., Sühs, K.-W., Wattjes, M. P., Stangel, M., & Skripuletz, T. (2019). Impact of the McDonald Criteria 2017 on early diagnosis of relapsing-remitting multiple sclerosis. Frontiers in Neurology, 10, 188. https://doi.org/10.3389/fneur.2019.00188
13. Perrot, S., Choy, E., Petersel, D., Ginovker, A., & Kramer, E. (2012). Survey of physician experiences and perceptions about the diagnosis and treatment of fibromyalgia. BMC health services research, 12, 356. https://doi.org/10.1186/1472-6963-12-356
14. Fitzcharles MA, Cohen SP, Clauw DJ, Littlejohn G, Usui C, Häuser W. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021;397(10289):2098-2110. https://pubmed.ncbi.nlm.nih.gov/34062144/
15. Clauw, D. J., Arnold, L. M., McCarberg, B. H., & FibroCollaborative (2011). The science of fibromyalgia. Mayo Clinic proceedings, 86(9), 907–911. https://doi.org/10.4065/mcp.2011.0206
16. Bhargava J, Goldin J. Fibromyalgia. [Updated 2025 Jan 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK540974/
17. Moshrif, A., Mosallam, A., Abu-Zaid, M. H., & Gouda, W. (2023). Evaluating the Effect of Delayed Diagnosis on Disease Outcome in Fibromyalgia: A Multi-Center Cross-Sectional Study. Journal of pain research, 16, 1355–1365. https://doi.org/10.2147/JPR.S381314
18. Kang, J. H., Choi, S. E., Xu, H., Park, D. J., Lee, J. K., & Lee, S. S. (2021). Comparison of the AAPT Fibromyalgia Diagnostic Criteria and Modified FAS Criteria with Existing ACR Criteria for Fibromyalgia in Korean Patients. Rheumatology and therapy, 8(2), 1003–1014. https://doi.org/10.1007/s40744-021-00318-8

Kos D, Kerckhofs E, Carrea I, Verza R, Ramos M, Jansa J. Evaluation of the Modified Fatigue Impact Scale in four different European countries. Mult Scler. 2005 Feb;11(1):76-80. https://pubmed.ncbi.nlm.nih.gov/15732270/